Ioannis P. Capos - Training Manager Vian S.A. - Vianex SA | LinkedIn
Heart Valve Center Hirslanden | Heart Clinic Hirslanden Zurich
Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial - ScienceDirect
Tricuspid Regurgitation: Predicting the Need for Intervention, Procedural Success, and Recurrence of Disease | JACC: Cardiovascular Imaging
BIR Publications
Recordings CMR JOURNAL CLUB
Mareike GASTL | Heinrich-Heine-Universität Düsseldorf, Düsseldorf | HHU
Profile | Ioannis Kapos | NEJM Resident 360
Heart Clinic Hirslanden Zurich | Interdisciplinary Heart Team
Heart teams of the heart clinic
Ioannis Kapos – Medical Doctor – Heart Clinic Zurich (Switzerland) | LinkedIn
Tricuspid Regurgitation: Predicting the Need for Intervention, Procedural Success, and Recurrence of Disease | JACC: Cardiovascular Imaging
Cardiovascular Medicine - Collection 2017/6
Tricuspid Regurgitation: Predicting the Need for Intervention, Procedural Success, and Recurrence of Disease - ScienceDirect
Cardiovascular Medicine - Value of echocardiography in differentiation of acute dyspnoea
Ioannis Kapos MD | Cardiac Imaging and Cardiology Zurich
Tricuspid Regurgitation: Predicting the Need for Intervention, Procedural Success, and Recurrence of Disease - ScienceDirect
Recordings CMR JOURNAL CLUB
Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial - ScienceDirect
Dr. Rebecca T. Hahn, MD | New York, NY | Cardiologist | US News Doctors
Ioannis Kapos – Medical Doctor – Heart Clinic Zurich (Switzerland) | LinkedIn
Heart Clinic Zurich (Switzerland) | LinkedIn
